To build a preclinical platform that covered the broad disease spectrum of human lung cancer, the authors obtained lung cancer specimens from multiple sources, including sputum and circulating tumor cells, and generated a living biobank consisting of 43 lines of patient-derived lung cancer organoids.
[Cell Reports]